Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Apr 13  •  04:00PM ET
3.30
Dollar change
+0.22
Percentage change
7.14
%
Apr 13, 9:35 AMThe Oncology Institute generates $1.8 million Medicare savings in CMS Enhancing Oncology Model Performance Period 3
Index
RUT
P/E
-
EPS (ttm)
-0.56
Insider Own
34.43%
Shs Outstand
98.86M
Perf Week
2.80%
Market Cap
326.16M
Forward P/E
-
EPS next Y
-0.08
Insider Trans
1.74%
Shs Float
64.81M
Perf Month
25.95%
Enterprise Value
396.35M
PEG
-
EPS next Q
-0.08
Inst Own
35.72%
Perf Quarter
-21.05%
Income
-50.26M
P/S
0.65
EPS this Y
57.87%
Inst Trans
7.01%
Perf Half Y
-15.60%
Sales
502.73M
P/B
-
EPS next Y
64.84%
ROA
-28.37%
Perf YTD
-7.30%
Book/sh
-0.16
P/C
9.72
EPS next 5Y
-
ROE
-3407.86%
52W High
4.88 -32.38%
Perf Year
84.36%
Cash/sh
0.34
P/FCF
-
EPS past 3/5Y
-37.23% -17.58%
ROIC
-62.18%
52W Low
1.62 103.70%
Perf 3Y
425.81%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
25.81% 21.80%
Gross Margin
13.82%
Volatility
7.60% 9.75%
Perf 5Y
-67.49%
Dividend TTM
-
EV/Sales
0.79
EPS Y/Y TTM
20.34%
Oper. Margin
-7.18%
ATR (14)
0.26
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
1.35
Sales Y/Y TTM
27.79%
Profit Margin
-10.00%
RSI (14)
57.74
Dividend Gr. 3/5Y
- -
Current Ratio
1.59
EPS Q/Q
55.70%
SMA20
2.87%
Beta
0.20
Payout
-
Debt/Eq
-
Sales Q/Q
41.58%
SMA50
13.97%
Rel Volume
0.86
Prev Close
3.08
Employees
641
LT Debt/Eq
-
SMA200
-2.29%
Avg Volume
1.97M
Price
3.30
IPO
Jun 04, 2020
Option/Short
Yes / Yes
Trades
Volume
1,706,466
Change
7.14%
Date Action Analyst Rating Change Price Target Change
Nov-25-25Initiated Needham Buy $5
Jul-23-25Initiated Noble Capital Markets Outperform $8
Jul-16-25Initiated B. Riley Securities Buy $6
May-15-25Initiated BTIG Research Buy $7
Feb-26-24Resumed Jefferies Buy $2.50
Sep-14-22Initiated Guggenheim Buy $7
Aug-15-22Initiated Jefferies Buy $10
Apr-13-26 09:00AM
Apr-09-26 09:00AM
Apr-06-26 09:00AM
Mar-13-26 08:30AM
Mar-12-26 11:03PM
04:05PM Loading…
04:05PM
Mar-11-26 09:27AM
Feb-26-26 06:00PM
08:00AM
Feb-25-26 08:00AM
Feb-23-26 08:00AM
Jan-12-26 08:00AM
Jan-09-26 08:00AM
Jan-05-26 08:30AM
Dec-01-25 08:30AM
05:20AM Loading…
Nov-21-25 05:20AM
Nov-14-25 12:06AM
Nov-13-25 05:30PM
04:05PM
04:04PM
Nov-12-25 06:25PM
07:26AM
Nov-05-25 09:15AM
Nov-04-25 05:50PM
Oct-29-25 07:15AM
Oct-22-25 04:47PM
Oct-21-25 09:45AM
Oct-01-25 08:00AM
Sep-29-25 08:00AM
Sep-22-25 08:00AM
09:35AM Loading…
Sep-18-25 09:35AM
Sep-02-25 04:05PM
Aug-18-25 08:00AM
Aug-14-25 03:14AM
Aug-13-25 04:05PM
04:04PM
Jul-24-25 04:05PM
Jul-14-25 04:05PM
Jul-09-25 07:20AM
Jun-30-25 04:05PM
Jun-03-25 08:00AM
May-14-25 04:06PM
04:05PM
May-13-25 07:08PM
04:05PM
May-08-25 08:00AM
May-07-25 05:03PM
May-01-25 05:48PM
Apr-30-25 06:04AM
Apr-26-25 11:00AM
Apr-23-25 08:00AM
Apr-22-25 04:05PM
Apr-01-25 10:04AM
Mar-31-25 08:00AM
Mar-26-25 03:02AM
Mar-25-25 06:28PM
Mar-24-25 09:05AM
06:01AM
06:00AM
Mar-04-25 08:00AM
Feb-26-25 08:00AM
Dec-18-24 04:05PM
Nov-13-24 04:05PM
Nov-11-24 08:00AM
Nov-04-24 07:09PM
Oct-23-24 08:00AM
Oct-14-24 08:00AM
Sep-30-24 08:00AM
Sep-23-24 08:00AM
Aug-13-24 04:05PM
Jul-23-24 08:00AM
May-29-24 08:00AM
May-22-24 08:00AM
May-15-24 03:14AM
May-14-24 06:05PM
04:05PM
May-07-24 04:05PM
Apr-23-24 08:00AM
Apr-08-24 08:00AM
Apr-04-24 08:00AM
Apr-01-24 01:35PM
Mar-27-24 08:52PM
05:34PM
04:05PM
Mar-21-24 09:35AM
Mar-14-24 08:09AM
Mar-06-24 08:00AM
Feb-27-24 04:05PM
Feb-20-24 08:00AM
Jan-25-24 08:00AM
Dec-04-23 08:00AM
Nov-16-23 05:04AM
Nov-11-23 12:43PM
Nov-08-23 05:50PM
04:05PM
Oct-18-23 08:03AM
Oct-11-23 04:05PM
Sep-26-23 04:05PM
Sep-18-23 08:00AM
Aug-09-23 08:10AM
The Oncology Institute, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chernett Jorey10% OwnerApr 09 '26Buy3.1020,00062,00010,499,358Apr 13 09:03 AM
Chernett Jorey10% OwnerMar 27 '26Buy2.9627,42981,19010,479,358Mar 30 09:38 AM
Chernett Jorey10% OwnerMar 26 '26Buy3.1550,000157,50010,451,929Mar 27 09:34 AM
Chernett Jorey10% OwnerMar 24 '26Buy3.11125,000388,75010,401,929Mar 25 09:33 AM
Chernett Jorey10% OwnerMar 20 '26Buy3.3525,00083,75010,276,929Mar 23 09:33 AM
Chernett Jorey10% OwnerMar 13 '26Buy2.92263,000767,96010,115,944Mar 17 07:40 PM
Chernett Jorey10% OwnerMar 17 '26Buy3.4275,000256,50010,251,929Mar 17 07:40 PM
Chernett Jorey10% OwnerMar 16 '26Buy3.2960,985200,64110,176,929Mar 17 07:40 PM
Carter Robert RossChief Financial OfficerJan 02 '26Sale3.56247879235,122Jan 05 05:04 PM
Hively BradDirectorDec 15 '25Sale3.7713,33350,291683,721Dec 16 04:30 PM
BRADFORD DANIEL HIVELYDirectorDec 15 '25Proposed Sale3.7713,33350,291Dec 15 04:07 PM
Pacala Mark LDirectorNov 18 '25Sale4.0050,000200,000174,971Nov 20 04:55 PM
MARK PACALADirectorNov 18 '25Proposed Sale4.0050,000200,000Nov 18 04:05 PM
M33 Growth I L.P.DirectorSep 04 '25Sale3.096,018,16818,596,1397,932,389Sep 05 06:12 AM
M33 Growth I L.P.DirectorSep 04 '25Sale3.09681,8322,106,861590,892Sep 05 06:12 AM
Hively BradDirectorAug 19 '25Sale4.0620,22182,097622,980Aug 21 03:13 PM
M33 Growth I L.P.DirectorJun 05 '25Sale3.05673,6762,054,71213,950,557Jun 09 04:15 PM
M33 Growth I L.P.DirectorJun 05 '25Sale3.0576,324232,7881,272,724Jun 09 04:15 PM
Hively BradDirectorJun 03 '25Option Exercise0.901,867,6051,682,5242,579,638Jun 05 06:51 PM
Hively BradDirectorJun 03 '25Sale2.871,976,1375,672,106603,501Jun 05 06:51 PM
TOI M, LLC10% OwnerJun 05 '25Proposed Sale3.20127,207407,062Jun 05 06:17 PM
M33 Growth I L.P.10% OwnerJun 05 '25Proposed Sale3.201,122,7933,592,938Jun 05 06:13 PM
BRADFORD DANIEL HIVELYDirectorJun 03 '25Proposed Sale2.8739,600113,652Jun 03 05:08 PM
BRADFORD DANIEL HIVELYDirectorJun 03 '25Proposed Sale2.871,936,5375,557,861Jun 03 04:27 PM
M33 Growth I L.P.DirectorMay 20 '25Sale2.711,796,4684,873,63814,624,233May 22 07:38 PM
M33 Growth I L.P.DirectorMay 20 '25Sale2.71203,532552,1621,349,048May 22 07:38 PM
TOI M, LLC10% OwnerMay 20 '25Proposed Sale3.06203,532622,808May 20 06:25 PM
M33 Growth I L.P.10% OwnerMay 20 '25Proposed Sale3.061,796,4685,497,192May 20 06:19 PM
Last Close
Apr 13  •  04:00PM ET
2.69
Dollar change
+0.05
Percentage change
1.89
%
AIRS Airsculpt Technologies Inc daily Stock Chart
Index
RUT
P/E
-
EPS (ttm)
-0.19
Insider Own
91.19%
Shs Outstand
64.46M
Perf Week
-13.23%
Market Cap
189.77M
Forward P/E
-
EPS next Y
-0.04
Insider Trans
1.18%
Shs Float
6.22M
Perf Month
23.39%
Enterprise Value
266.88M
PEG
-
EPS next Q
-0.02
Inst Own
24.53%
Perf Quarter
19.03%
Income
-11.67M
P/S
1.25
EPS this Y
0.00%
Inst Trans
-3.62%
Perf Half Y
-68.72%
Sales
151.82M
P/B
1.98
EPS next Y
30.00%
ROA
-5.87%
Perf YTD
35.86%
Book/sh
1.36
P/C
22.46
EPS next 5Y
-
ROE
-13.97%
52W High
12.00 -77.58%
Perf Year
47.80%
Cash/sh
0.12
P/FCF
275.03
EPS past 3/5Y
9.87% -
ROIC
-7.36%
52W Low
1.51 78.15%
Perf 3Y
-49.44%
EV/EBITDA
20.90
Sales past 3/5Y
-3.47% 19.32%
Gross Margin
50.95%
Volatility
12.12% 16.89%
Perf 5Y
-
EV/Sales
1.76
EPS Y/Y TTM
-34.41%
Oper. Margin
-0.01%
ATR (14)
0.38
Perf 10Y
-
Quick Ratio
0.55
Sales Y/Y TTM
-15.82%
Profit Margin
-7.68%
RSI (14)
51.01
Current Ratio
0.55
EPS Q/Q
122.98%
SMA20
-5.09%
Beta
2.18
Debt/Eq
0.98
Sales Q/Q
-14.64%
SMA50
15.09%
Rel Volume
0.24
Prev Close
2.64
Employees
363
LT Debt/Eq
0.81
SMA200
-44.17%
Avg Volume
2.80M
Price
2.69
IPO
Oct 29, 2021
Option/Short
Yes / Yes
Trades
Volume
682,489
Change
1.89%
Date Action Analyst Rating Change Price Target Change
Oct-17-24Initiated BTIG Research Neutral
May-14-24Downgrade Leerink Partners Outperform → Market Perform $8.25 → $5
Nov-11-22Downgrade Piper Sandler Overweight → Neutral $4
Jun-16-22Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $8.50
Nov-23-21Initiated SVB Leerink Outperform $26
Nov-23-21Initiated Raymond James Outperform $18
Nov-23-21Initiated Piper Sandler Overweight $22
Nov-23-21Initiated Morgan Stanley Overweight $17
Apr-06-26 06:30AM
Apr-02-26 03:00PM
12:46PM
06:30AM
Mar-31-26 05:09PM
06:45AM Loading…
Mar-16-26 06:45AM
Mar-06-26 01:00PM
Feb-24-26 10:45PM
Nov-17-25 05:32PM
Nov-07-25 07:15AM
06:00AM
Nov-06-25 07:24AM
Nov-05-25 06:25PM
Oct-31-25 06:45AM
Oct-23-25 11:10AM
09:40AM Loading…
Sep-26-25 09:40AM
Sep-19-25 12:00PM
Sep-03-25 12:00PM
Aug-19-25 08:00AM
Aug-13-25 06:00AM
Aug-08-25 09:40AM
Aug-02-25 03:07AM
Aug-01-25 07:10AM
06:00AM
Jul-31-25 09:30AM
Jul-25-25 06:45AM
Jul-02-25 02:39PM
Jun-16-25 06:45AM
Jun-11-25 04:05PM
Jun-10-25 06:55AM
04:25PM Loading…
Jun-09-25 04:25PM
May-27-25 12:00PM
May-03-25 03:02AM
May-02-25 11:02PM
01:12PM
07:10AM
06:00AM
May-01-25 09:32AM
Apr-25-25 06:45AM
Apr-17-25 05:27AM
Apr-14-25 07:18AM
Apr-02-25 06:07AM
Apr-01-25 12:16PM
Mar-26-25 05:33AM
Mar-24-25 05:29AM
Mar-15-25 03:02AM
12:48AM
Mar-14-25 07:10AM
06:00AM
Mar-11-25 09:15AM
Mar-06-25 06:45AM
Jan-13-25 06:45AM
Jan-07-25 06:45AM
Dec-17-24 06:45AM
Dec-10-24 10:42PM
Dec-02-24 01:22PM
Nov-09-24 02:04AM
01:34AM
Nov-08-24 09:30AM
07:10AM
06:00AM
Nov-07-24 07:09AM
Nov-05-24 11:17AM
Oct-24-24 06:30AM
Oct-15-24 08:05AM
Oct-01-24 12:48PM
Sep-24-24 01:30PM
Sep-19-24 08:32AM
Aug-23-24 08:30AM
Aug-19-24 12:00PM
Aug-10-24 08:18AM
Aug-09-24 10:52AM
09:30AM
07:25AM
06:33AM
06:10AM
06:00AM
Aug-07-24 09:15AM
Jul-25-24 06:45AM
Jul-15-24 11:57AM
Jun-17-24 06:00AM
May-31-24 09:36AM
May-24-24 09:55AM
09:35AM
May-13-24 03:06AM
May-11-24 10:19AM
May-10-24 03:32PM
01:48PM
10:53AM
09:30AM
07:15AM
06:00AM
May-08-24 09:15AM
Apr-30-24 07:00AM
Apr-29-24 08:30AM
Mar-19-24 08:30AM
Mar-18-24 07:00AM
Mar-12-24 03:59PM
Mar-10-24 10:18AM
Mar-07-24 07:00AM
AirSculpt Technologies, Inc. is a fat removal treatment under its brand, Elite Body Sculpture.. It provides custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. The company was founded by Aaron J. Rollins in 2012 and is headquartered in Miami Beach, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chernett Jorey10% OwnerApr 07 '26Buy2.9360,000175,8006,993,761Apr 08 09:09 AM
Chernett Jorey10% OwnerApr 03 '26Buy2.8290,000253,8006,933,761Apr 06 09:34 AM
Chernett Jorey10% OwnerMar 23 '26Buy2.9150,000145,5006,843,761Mar 25 01:43 PM
Chernett Jorey10% OwnerMar 20 '26Buy2.7740,000110,8006,793,761Mar 23 09:33 AM
Chernett Jorey10% OwnerMar 19 '26Buy2.6477,702205,1336,753,761Mar 20 09:33 AM
Chernett Jorey10% OwnerMar 17 '26Buy2.5683,000212,4806,676,059Mar 18 10:36 AM
Chernett Jorey10% OwnerMar 16 '26Buy2.43105,848257,2116,592,059Mar 16 06:43 PM
Chernett Jorey10% OwnerMar 11 '26Buy2.1588,000189,2006,486,211Mar 11 05:30 PM
Chernett Jorey10% OwnerMar 06 '26Buy2.0045,60091,2006,398,211Mar 09 08:40 AM
Chernett Jorey10% OwnerMar 03 '26Buy1.7180,000136,8006,322,611Mar 04 06:58 PM
Chernett Jorey10% OwnerMar 04 '26Buy1.8730,00056,1006,352,611Mar 04 06:58 PM
Feinstein Adam TDirectorJun 09 '25Buy4.001,000,0004,000,00014,038,819Jun 11 05:06 PM
Rollins AaronExecutive ChairmanMay 19 '25Buy3.602,1187,62915,146,039May 20 04:11 PM
Jashnani YogeshChief Executive OfficerMay 07 '25Buy2.657,00018,532464,879May 07 05:56 PM
Last Close
Apr 13  •  04:00PM ET
1.39
Dollar change
+0.04
Percentage change
2.96
%
STIM Neuronetics Inc daily Stock Chart
Index
RUT
P/E
-
EPS (ttm)
-0.60
Insider Own
48.22%
Shs Outstand
68.99M
Perf Week
-21.02%
Market Cap
96.29M
Forward P/E
-
EPS next Y
-0.32
Insider Trans
8.47%
Shs Float
35.87M
Perf Month
9.45%
Enterprise Value
156.32M
PEG
-
EPS next Q
-0.17
Inst Own
34.52%
Perf Quarter
-32.85%
Income
-39.00M
P/S
0.65
EPS this Y
19.41%
Inst Trans
6.50%
Perf Half Y
-52.72%
Sales
149.16M
P/B
4.29
EPS next Y
32.82%
ROA
-27.61%
Perf YTD
0.72%
Book/sh
0.32
P/C
2.82
EPS next 5Y
32.68%
ROE
-155.73%
52W High
4.85 -71.34%
Perf Year
-63.32%
Cash/sh
0.49
P/FCF
-
EPS past 3/5Y
24.64% 16.51%
ROIC
-36.41%
52W Low
0.80 73.75%
Perf 3Y
-39.83%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
31.76% 24.81%
Gross Margin
46.40%
Volatility
14.51% 16.34%
Perf 5Y
-89.06%
Dividend TTM
-
EV/Sales
1.05
EPS Y/Y TTM
56.27%
Oper. Margin
-21.08%
ATR (14)
0.19
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
1.87
Sales Y/Y TTM
99.17%
Profit Margin
-26.15%
RSI (14)
47.92
Dividend Gr. 3/5Y
- -
Current Ratio
2.02
EPS Q/Q
68.60%
SMA20
-3.05%
Beta
0.91
Payout
-
Debt/Eq
4.03
Sales Q/Q
85.73%
SMA50
-3.45%
Rel Volume
0.85
Prev Close
1.35
Employees
658
LT Debt/Eq
3.79
SMA200
-42.12%
Avg Volume
2.21M
Price
1.39
IPO
Jun 28, 2018
Option/Short
Yes / Yes
Trades
Volume
1,867,339
Change
2.96%
Date Action Analyst Rating Change Price Target Change
Aug-13-24Downgrade William Blair Outperform → Mkt Perform
Oct-13-21Downgrade William Blair Outperform → Mkt Perform
Oct-13-21Downgrade BTIG Research Buy → Neutral
Jan-22-21Upgrade William Blair Mkt Perform → Outperform
Feb-06-20Initiated BTIG Research Buy $11
Jul-24-18Initiated Canaccord Genuity Buy
Apr-13-26 08:32AM
Apr-07-26 07:00AM
Apr-06-26 04:30PM
04:05PM
Mar-17-26 12:46PM
08:17AM Loading…
08:17AM
07:50AM
07:45AM
Mar-03-26 08:30AM
Feb-11-26 12:20AM
Feb-10-26 04:34PM
Nov-20-25 08:30AM
Nov-12-25 10:33AM
Nov-04-25 04:08PM
08:40AM
07:39AM Loading…
07:39AM
07:05AM
Nov-03-25 08:09AM
Oct-31-25 04:30PM
Oct-30-25 08:32AM
Oct-21-25 08:30AM
Sep-17-25 08:32AM
Sep-02-25 03:49AM
Aug-06-25 04:45PM
Aug-05-25 08:20AM
07:19AM
07:05AM
Aug-04-25 04:30PM
10:04AM
Jul-30-25 08:32AM
08:30AM Loading…
Jul-22-25 08:30AM
Jul-15-25 07:30AM
Jul-09-25 07:20AM
Jun-19-25 07:00PM
Jun-10-25 08:31AM
Jun-02-25 04:30PM
May-14-25 08:31AM
May-07-25 03:09AM
May-06-25 08:20AM
07:20AM
07:10AM
May-05-25 04:30PM
07:40AM
Apr-30-25 05:50AM
Apr-22-25 08:30AM
Apr-02-25 03:26PM
Mar-31-25 08:31AM
Mar-29-25 11:45PM
Mar-27-25 04:30PM
Mar-18-25 09:55AM
Mar-05-25 02:06AM
Mar-04-25 11:29PM
07:36AM
07:10AM
Mar-03-25 04:30PM
07:20AM
Feb-22-25 05:08PM
Feb-21-25 08:30AM
Feb-07-25 04:30PM
07:54AM
Feb-06-25 04:23PM
Feb-03-25 07:27PM
Jan-29-25 08:31AM
Jan-13-25 08:00AM
Dec-18-24 04:30PM
Dec-16-24 04:30PM
Dec-10-24 10:00AM
Nov-20-24 08:30AM
Nov-13-24 02:10AM
Nov-12-24 06:45PM
04:30PM
08:20AM
07:19AM
07:10AM
Nov-11-24 07:26AM
Oct-29-24 04:30PM
Oct-14-24 08:31AM
Oct-04-24 08:33AM
Sep-25-24 08:31AM
Sep-19-24 08:31AM
Sep-16-24 08:32AM
Sep-03-24 08:29AM
Aug-20-24 08:29AM
Aug-15-24 05:42AM
Aug-13-24 12:56PM
12:47PM
09:45AM
Aug-12-24 08:25AM
07:19AM
07:15AM
07:10AM
Aug-05-24 04:36PM
Aug-01-24 08:29AM
Jul-31-24 08:30AM
Jul-30-24 08:30AM
Jul-29-24 08:30AM
Jul-22-24 08:31AM
Jul-18-24 10:30AM
Jul-11-24 12:53PM
08:36AM
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 2003 and is headquartered in Malvern, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chernett Jorey10% OwnerMar 30 '26Buy1.25385,442481,8029,778,988Mar 30 07:41 PM
Chernett Jorey10% OwnerMar 27 '26Buy1.35500,000675,0009,393,276Mar 30 09:37 AM
Chernett Jorey10% OwnerMar 25 '26Buy1.40125,000175,0008,868,276Mar 27 09:33 AM
Chernett Jorey10% OwnerMar 26 '26Buy1.4425,00036,0008,893,276Mar 27 09:33 AM
Pfanstiel StevenEVP, CFO and TreasurerMar 19 '26Sale1.3416,43122,018828,781Mar 24 05:52 PM
Sullivan Keith JFormer Officer & DirectorMar 19 '26Sale1.3446,28962,0271,590,924Mar 24 05:50 PM
MACAN WILLIAM ANDREWEVP, CLO and CSMar 19 '26Sale1.3416,00521,447897,270Mar 24 05:48 PM
Chernett Jorey10% OwnerMar 20 '26Buy1.41169,472238,9568,743,276Mar 23 09:34 AM
Chernett Jorey10% OwnerMar 18 '26Buy1.35607,400819,9908,123,804Mar 20 08:51 AM
Chernett Jorey10% OwnerMar 19 '26Buy1.33450,000598,5008,573,804Mar 20 08:51 AM
MACAN WILLIAM ANDREWOfficerMar 19 '26Proposed Sale1.3216,00521,123Mar 19 04:36 PM
Sullivan Keith JOfficerMar 19 '26Proposed Sale1.3246,28961,092Mar 19 04:25 PM
Chernett Jorey10% OwnerMar 17 '26Buy1.16531,000615,9607,516,404Mar 18 10:36 AM
MACAN WILLIAM ANDREWEVP, CLO and CSMar 04 '26Sale1.34609816879,525Mar 06 04:29 PM
MACAN WILLIAM ANDREWOfficerMar 04 '26Proposed Sale1.34609814Mar 04 03:09 PM
MACAN WILLIAM ANDREWEVP, CLO and CSFeb 26 '26Sale1.353,4274,626880,134Feb 27 04:34 PM
Sullivan Keith JPresident and CEOFeb 26 '26Sale1.358,45211,4101,524,713Feb 27 04:33 PM
Sullivan Keith JOfficerFeb 26 '26Proposed Sale1.348,45211,366Feb 26 03:33 PM
MACAN WILLIAM ANDREWOfficerFeb 26 '26Proposed Sale1.343,4274,609Feb 26 03:16 PM
Sullivan Keith JPresident and CEOFeb 12 '26Sale1.6533,84755,8481,533,165Feb 18 05:44 PM
MACAN WILLIAM ANDREWEVP, CLO and CSFeb 12 '26Sale1.6514,12023,298673,561Feb 18 05:42 PM
MACAN WILLIAM ANDREWEVP, CLO and CSFeb 10 '26Sale1.553,4855,402687,681Feb 12 04:32 PM
Sullivan Keith JPresident and CEOFeb 10 '26Sale1.5540,97663,5131,567,012Feb 12 04:31 PM
Sullivan Keith JOfficerFeb 12 '26Proposed Sale1.6533,84755,712Feb 12 03:19 PM
MACAN WILLIAM ANDREWOfficerFeb 12 '26Proposed Sale1.6514,12023,242Feb 12 03:12 PM
MACAN WILLIAM ANDREWOfficerFeb 10 '26Proposed Sale1.553,4855,392Feb 10 04:28 PM
Sullivan Keith JOfficerFeb 10 '26Proposed Sale1.5540,97663,398Feb 10 04:14 PM
Madryn Asset Management, LP10% OwnerAug 08 '25Sale3.723,500,00013,020,0001,142,351Aug 12 04:15 PM
MADRYN HEALTH PRTS II (CAY MAS10% OwnerAug 08 '25Proposed Sale3.722,925,55410,883,061Aug 08 04:55 PM
MADRYN HEALTH PARTNERS II, LP10% OwnerAug 08 '25Proposed Sale3.72192,806717,238Aug 08 04:54 PM
MADRYN SELECT OPPORTUNITIES, L10% OwnerAug 08 '25Proposed Sale3.72381,6401,419,701Aug 08 04:54 PM
Furlong StephenOfficerAug 07 '25Proposed Sale4.0998,635403,385Aug 07 04:52 PM
Furlong StephenEVP, CFO and TreasurerMay 12 '25Sale4.27193,460826,074416,593May 14 05:05 PM
Furlong StephenEVP, CFO and TreasurerMay 13 '25Sale4.166,54027,206410,053May 14 05:05 PM
Furlong StephenOfficerMay 13 '25Proposed Sale4.166,54027,190May 13 12:54 PM
Furlong StephenOfficerMay 12 '25Proposed Sale4.27193,460826,283May 12 04:40 PM